financetom
Business
financetom
/
Business
/
All you need to know about US Prez Joe Biden’s crypto executive order
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
All you need to know about US Prez Joe Biden’s crypto executive order
Mar 11, 2022 10:32 AM

US President Joe Biden on March 10 signed the ‘Executive Order on Ensuring Responsible Development of Digital Assets.’ The executive order is the first comprehensive set of rules for governing cryptocurrencies and other virtual assets in the US.

The US has once again emerged as a centre of crypto activity. The country is now home to over 35 percent of Bitcoin’s mining volume capacity and to over 100 million cryptocurrency investors through its various cryptocurrency exchanges in the country.

Also read: All about ‘Russian Ethereum’ that has skyrocketed 200% since Ukraine war

"The

Also read: Women warriors in crypto taking the 'Crypto Bro' culture head on

The executive order is widely being seen as being ‘neutral’ towards digital currencies as the regulations and orders do not seem to be setting the stage for a potential ban of all virtual currencies. At the same time, the order also does not legalise these currencies.

The order has asked a number of federal agencies to develop responses to the developing cryptocurrency technologies. This will mean different things for each department. But among these directives, is also the direction to the Federal Reserve to study the possibility of a ‘digital dollar’ or a Central Bank Digital Currency (CBDC).

Also read: 'Crypto winter' unlikely in digital asset industry, says Bank of America

Additionally, the EO also sets out six key priorities for the US government regarding cryptocurrencies. These include consumer protection, use of cryptocurrency for criminal priorities, volatility of cryptocurrency, financial inclusion, and responsible innovation when it comes to newer cryptocurrency technologies.

(Edited by : Shoma Bhattacharjee)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marchex Joining Microsoft's Cloud AI Partner Program
Marchex Joining Microsoft's Cloud AI Partner Program
Dec 11, 2024
09:33 AM EST, 12/11/2024 (MT Newswires) -- Marchex ( MCHX ) said Wednesday it has signed an agreement to join Microsoft's ( MSFT ) Cloud AI Partner Program. The move will give Marchex ( MCHX ) the ability to transact via Microsoft's ( MSFT ) Azure Marketplace, which will connect clients to its products, the company said. The products will...
Wells Fargo CEO expresses more confidence in regulatory fixes
Wells Fargo CEO expresses more confidence in regulatory fixes
Dec 11, 2024
NEW YORK (Reuters) - Wells Fargo ( WFC ) CEO Charlie Scharf expressed more confidence on Wednesday in the bank's progress to fix compliance problems after its years-long fake accounts scandal, detailing its efforts to implement risk controls. For every one of our consent orders that we have, for every one of our regulatory deliverables, we have extremely detailed plans...
Wells Fargo CEO expresses more confidence in regulatory fixes
Wells Fargo CEO expresses more confidence in regulatory fixes
Dec 11, 2024
NEW YORK, Dec 11 (Reuters) - Wells Fargo ( WFC ) CEO Charlie Scharf expressed more confidence on Wednesday in the bank's progress to fix compliance problems after its years-long fake accounts scandal, detailing its efforts to implement risk controls. For every one of our consent orders that we have, for every one of our regulatory deliverables, we have extremely...
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug
Dec 11, 2024
On Wednesday, Pharming Group N.V. ( PHAR ) revealed topline results of data from its Phase 3 trial evaluating leniolisib in children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS). APDS is a genetic disorder that impairs the immune system. Individuals with this condition often have low numbers of white blood cells, particularly certain types of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved